Recent share performance and business mix

Chubb (CB) has seen its stock pull back recently, with the price down about 2% over the past week, around 4% over the past month, and roughly 5% over the past 3 months.

At a recent close of US$316.01 and a market value of about US$124.9b, the insurer runs a broad mix of property and casualty, crop, life, and reinsurance operations across North America and overseas markets.

For investors tracking fundamentals, Chubb reports annual revenue of US$60,988.0m and net income of US$11,299.0m. Revenue and net income are both slightly lower on an annual growth basis.

Recent trading has been softer, with the stock showing weaker short term share price momentum but still delivering a 13.77% 1 year total shareholder return and a 105.21% 5 year total shareholder return, which keeps the longer term picture more constructive.

If Chubb has sharpened your focus on financials, it can be useful to see how other insurers compare on underwriting risk and capital strength, starting with 20 top founder-led companies

With Chubb trading below one set of estimated intrinsic values and below some analyst targets after a softer patch in the share price, you have to ask: is this a valuation gap, or has the market already priced in future growth?

Most Popular Narrative: 27.9% Overvalued

According to the most widely followed narrative on Chubb, the estimated fair value of US$247.08 sits well below the recent close at US$316.01, which frames the stock as trading rich to that model.

Chubb Limited’s future growth is influenced by several strategic initiatives, market trends, and external factors.

By capitalizing on these opportunities and navigating the challenges of the evolving insurance landscape, Chubb is well-positioned to maintain its competitive edge and achieve sustained growth.

The narrative leans heavily on long term earnings power, a firm profit margin profile, and a valuation framework that blends revenue trajectories with a specific discount rate and exit multiple logic. The real interest lies in how those building blocks combine to justify a fair value well below where the stock trades today.

Result: Fair Value of US$247.08 (OVERVALUED)

However, this overvaluation story could be challenged if underwriting risks flare up through large catastrophe losses or if rising competition pressures pricing and profit margins.

Another take on value: earnings multiples send a different signal

The user narrative argues Chubb is 27.9% overvalued versus a fair value of $247.08, but simple earnings ratios tell a different story. At a P/E of 10.8x, the stock sits at the same level as the wider US insurance group, higher than peer averages of 8x, yet slightly below a fair ratio of 11.2x derived from regression work. That mix of “about fair” on one yardstick and “rich” on another leaves a real question: is the risk skewed to re rating, or to the narrative winning out.

Next Steps

The mix of viewpoints here is clear, with some investors cautious and others seeing upside. It therefore makes sense to review the facts quickly and decide where you stand by weighing up the 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If you stop your research with one insurer, you risk missing stocks that better fit your goals, risk tolerance, and income needs across the market.

• Target potential mispricings and widen your opportunity set by scanning 47 high quality undervalued stocks that pair solid fundamentals with cheaper P/E or asset backing.
• Strengthen your focus on resilience by checking 68 resilient stocks with low risk scores that score well on financial health and show fewer red flags on volatility and balance sheets.
• Broaden your watchlist with fresh prospects using a screener containing 23 high quality undiscovered gems that spotlight companies with robust fundamentals yet limited current attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.